Drug Audits Of 340B Providers Will Be Both Random And Targeted, HRSA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The Health Resources and Services Administration has begun random and targeted audits of health care providers participating in the federal 340B drug discount program to help ensure products are not being diverted for other uses or resulting in manufacturers paying double discounts to Medicaid.